With over 6.72 million Aurora Cannabis Inc (ACB) shares trading Monday and a closing price of $0.48 on the day, the dollar volume was approximately $3.23 million. The shares have shown a negative half year performance of -28.49% and its price on 11/20/23 gained nearly 3.07%. Currently, there are 434.84M common shares owned by the public and among those 433.52M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 9 analysts who have offered their price forecasts for ACB have a consensus price objective of $0.68. The analysts have set the share’s price value over the next 12 months at a high of $1.00 and a low of $0.51. The average price target is 29.41% above its recent price level and an upside to the estimated low will see the stock gain 5.88% over that period. But an upside of 52.0% will see the stock hit the forecast high price target while median target price for the stock is $0.58.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 26 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 19 of these insider trades were purchases, accounting for 1,348,761 shares. Insider sales of the common stock occurred on 7 occasions, with total insider shares sold totaling 111,140 shares.
The top 3 mutual fund holders in Aurora Cannabis Inc are ETFMG Alternative Harvest ETF, Global X Cannabis ETF, and Horizons Marijuana Life Sciences. ETFMG Alternative Harvest ETF owns 14.66 million shares of the company’s stock, all valued at over $6.47 million. Horizons Marijuana Life Sciences sold 20856.0 shares to bring its total holdings to over 1.91 million shares at a value of $0.84 million. Horizons Marijuana Life Sciences now owns shares totaling to 0.40% of the shares outstanding.
However, the script later moved the day high at 0.4849, up 3.07%. The company’s stock has a 5-day price change of 1.15% and -2.66% over the past three months. ACB shares are trading -48.35% year to date (YTD), with the 12-month market performance down to -67.14% lower. It has a 12-month low price of $0.41 and touched a high of $1.48 over the same period. ACB has an average intraday trading volume of 21.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.44%, -17.14%, and -22.51% respectively.
Institutional ownership of Aurora Cannabis Inc (NASDAQ: ACB) shares accounts for 9.59% of the company’s 434.84M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $207.20M and a beta (3y monthly) value of 2.43. The stock’s trailing 12-month PE ratio is 0.60, while the earnings-per-share (ttm) stands at $0.80. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.01% over the week and 7.30% over the month.
Analysts forecast that Aurora Cannabis Inc (ACB) will achieve an EPS of -$0.03 for the current quarter, -$0.03 for the next quarter and -$0.05 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.03 while analysts give the company a high EPS estimate of -$0.03. Comparatively, EPS for the current quarter was -$0.13 a year ago. Earnings per share for the fiscal year are expected to increase by 80.71%, and 49.11% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 9 brokerage firm advisors rate Aurora Cannabis Inc (ACB) as a “Moderate Buy” at a consensus score of 2.89. Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 8 of the 9 advise that investors “hold,” and 0 rated it as a “Sell.”
